0 Presentation to Investors and Analysts HSBC Holdings plc 1Q22 Results -- 1 of 32 -- 1Q22 results Appendix Our purpose, values and ambition support the execution of our strategy Opening up a world of opportunity Our purpose Our values Our strategy Our ambition To be the preferred international financial partner for our clients We value difference We succeed together We take responsibility We get it done Focus on strengths Digitise at scale Energise for growth Transition to net zero -- 2 of 32 -- 2 1Q22 results Appendix 1Q22 highlights 3 Good cost control, with adjusted costs down 2% vs. 1Q21; firmly on track to meet our FY22 target of stable adjusted costs 5 CET1 ratio1 of 14.1%, down 1.7ppts vs. 4Q21, of which c.0.8ppts related to expected regulatory impacts and c.0.4ppts related to adverse fair value movements through OCI 2 More normalised ECL, with a charge of $0.6bn (25bps of average loans). Stage 3 charges remain low 1 1Q22 reported revenue of $12.5bn, down $0.5bn (4%) vs. 1Q21; reported PBT of $4.2bn down $1.6bn (28%) vs. 1Q21, with the positive impact from higher rates more than offset by lower non-NII and higher ECL 4 Strong adjusted lending growth of $21bn (2%) vs. 4Q21, particularly CMB and GBM in Trade, supported by strong mortgage growth in WPB A reconciliation of reported results to adjusted results can be found on slide 15, the remainder of the presentation unless otherwise stated, is presented on an adjusted basis Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary 6 Strategy execution is on track -- 3 of 32 -- 3 1Q22 results Appendix Business highlights Global business highlights Geographic highlights Sustainability Operations and Technology * Includes renewal and refinancing activity. Note, clients may elect not to draw down on approved limits; from 3Q21 we have chosen to exclude past approvals from the same client within 60 calendar days from approved limit analysis, comparative data have been re-presented accordingly  Strong Insurance performance excluding adverse market impacts; VNB up 25% vs. 1Q21  Mortgage growth of $6bn vs. 4Q21, particularly in the UK ($3bn)  Strong CMB lending growth, up $9bn (3%) vs. 4Q21, with C&L up $6bn and trade balances up $3bn  CMB fees up 13% vs. 1Q21 across all regions and particularly in GLCM and Trade  1Q22 CMB value of approved limits* of $58bn, c.$7bn higher vs. FY21 quarterly average of $51bn  Trade balances up $15bn (22%) vs. 1Q21 to $86bn  GLCM balances across CMB and GBM up $51bn (7%) vs. 1Q21 to $749bn  #1 in the EMEA IPO league tables with an 11% market share2 Per our announcement on 16 March 223, we have committed to: 1) Publish a bank-wide Climate Transition Plan in 2023 2) A science-aligned phase-down of fossil fuel financing 3) Undertake a review of and update our wider financing and investment policies critical to achieving net zero by 2050 Signed quantum computing partnership with IBM Adjusted PBT by region, $bn 1Q21 1Q22 Europe 1.5 0.7 o/w: UK RFB 1.1 1.3 o/w: HSBC Bank plc 0.8 0.2 Asia 3.8 2.9 o/w: Hong Kong 1.9 1.1 o/w: Asia ex-HK 1.9 1.8 MENA 0.3 0.4 North America 0.5 0.5 Latin America 0.2 0.2 Real estate footprint down 25% since FY19, or c.4.7 million sq. feet, with a further 7 buildings closed in 1Q22  Profitable in all regions  HSBC UK PBT up $0.2bn (14%) vs. 1Q21, good revenue growth supported by further ECL releases  MENA PBT up $0.1bn (21%) vs. 1Q21 driven by strong FX performance Top 3 globally for GSS bond issuance with a market share of 6.2% 4 -- 4 of 32 -- 4 1Q22 results Appendix Hong Kong and mainland China Hong Kong adjusted performance $m 1Q21 4Q21 1Q22 NII 1,815 1,838 1,896 Non-NII 2,163 1,255 1,342 Revenue 3,978 3,093 3,238 ECL (84) (479) (205) Costs (1,992) (1,992) (1,962) PBT* 1,908 626 1,072 Memo: WPB insurance market impacts (69) 91 (297) Mainland China adjusted performance $m 1Q21 4Q21 1Q22 NII 410 433 433 Non-NII 481 540 541 Revenue 891 973 974 ECL 17 (48) (73) Costs (636) (751) (703) Associates 716 578 672 PBT 988 752 870  1Q22 revenue up 9% vs. 1Q21; NII up 6% and non-NII up 12%  Costs up due to increased investments in technology  Lending up $6bn (11%) vs. 1Q21 to $56bn, of which CMB was $4bn (up 17%)  Increased stake in HSBC Qianhai Securities joint venture from 51% to 90%  Pinnacle Venture on track: c.700 Wealth Planners hired to date; total planned hires of c.3,000 in the next few years Hong Kong digital highlights 96% of WPB transactions completed digitally5 in FY21 HSBC Hong Kong became the first bank with approval to offer remote, branch-like sales and service activities (‘Home Banking’)  In 1Q22 Hong Kong was impacted by branch closures from government restrictions and muted market sentiment  1Q21 non-NII strong due to elevated levels of market activity, with good performance in Wealth distribution and Global Markets  1Q22 non-NII impacted by:  Adverse insurance market impact movements of $228m  Lower client activity drove lower equities brokerage income and markets-linked revenue  Despite a more subdued performance in parts of the business, Insurance sales were good: VNB up 20% vs. 1Q21 with a strong remote proposition  As of 19 April 22, all branches in Hong Kong have fully reopened  Interest rate rises are expected to support future NII growth  Client activity expected to return to normal levels over time 5 minute digital onboarding journeys now available * 1Q22 PBT includes associate income of $1m (1Q21: $6m; 4Q21:$4m) -- 5 of 32 -- 5 1Q22 results Appendix $m 1Q22 1Q21 Δ NII 6,999 6,338 10 % Non-NII 5,550 6,624 (16)% Revenue 12,549 12,962 (3)% ECL (642) 420 >(100)% Costs (7,857) (7,998) 2 % Associates 656 896 (27)% Adjusted PBT 4,706 6,280 (25)% Significant items and FX translation (540) (501) (8)% Reported PBT 4,166 5,779 (28)% Profit attributable to ordinary shareholders 2,803 3,880 (28)% Reported EPS, $ 0.14 0.19 $(0.05) Impact of sig items on reported EPS, $ (0.02) (0.03) $0.01 Reported RoTE6 (annualised), % 6.8 10.2 (3.4)ppts $bn 1Q22 4Q21 Δ Customer loans 1,055 1,034 2% Customer deposits 1,710 1,689 1% Reported RWAs 862 838 (3)% CET1 ratio1 , % 14.1 15.8 (1.7)ppts TNAV per share, $ 7.80 7.88 $0.08 1Q22 results summary  1Q22 reported PBT of $4.2bn; adjusted PBT of $4.7bn  NII of $7.0bn, up vs. 1Q21 reflecting interest rate rises and lending growth  Non-NII of $5.6bn, down vs. 1Q21, negatively impacted by $342m of adverse insurance market impact movements in WPB and slowdown in Asia Wealth following Covid-related restrictions  ECL charge of $0.6bn, including the impact of deterioration in the forward economic guidance and charges relating to Russian counterparties  Costs of $7.9bn, down vs. 1Q21 as increased investment in technology partly offset cost saves and lower performance related pay  Associate income of $0.7bn, a more normal performance due to the non-repeat of 1Q21 revaluation gains in BGF  Customer lending up $21bn vs. 4Q21, with strong growth across the global businesses  TNAV per share down $0.08 vs. 4Q21; profits were more than offset by negative fair value movements through OCI and FX -- 6 of 32 -- 6 1Q22 results Appendix (8)% Adjusted revenue performance 284 (335) Corporate Centre 1Q21 WPB CMB 12,549 (164) GBM (198) 1Q22 12,962 Revenue by global business*, $m  WPB down 6% vs. 1Q21. Personal banking up $216m (7%) from higher interest rates and balance sheet growth, offset by adverse insurance market impacts of $342m and lower Investment Distribution (down $218m, 21%)  CMB up 9% vs. 1Q21 with strong performance across CMB products reflecting balance sheet and fee growth, particularly GLCM (up $177m, 21%)  GBM down 4% vs. 1Q21, with strong client volumes and volatility benefitting Markets, with Global FX up $142m (15%). Banking up $62m (4%) primarily from higher rates and volumes in GLCM (up $89m, 21%). Principal Investments down $112m due to lower revaluation gains Includes $(342)m of insurance market impacts Net fee income by global business, $m  Group net fee income down 8% vs. 1Q21  WPB fees down 15% vs. 1Q21 due to lower equity brokerage activity  CMB fee income up 13% vs. 1Q21, growth across all CMB products  GBM fees down 15% vs. 1Q21, lower client activity in MSS was partly offset by good growth in GLCM 1,601 1,349 1,365 868 922 979 924 818 788 3,084 4Q21 (5) (2) 1Q21 1Q22 (6) 3,391 3,126 1% GBM WPB CMB Corporate Centre * Using March 2022 average FX rates, FY21 adjusted revenue would decrease by c.$1.4bn, and FY21 adjusted costs would decrease by c.$0.9bn, primarily due to the weakening of GBP against USD -- 7 of 32 -- 7 1Q22 results Appendix 2,179 2,199 2,208 2,251 2,259 121bps 120bps 119bps 126bps 119bps 7bps Net interest income and margin Reported NIM trend  1Q22 reported NII of $7.0bn was up $0.5bn (7%) vs. 1Q21 due to the impact of rising global interest rates. Reported AIEAs increased $80bn (4%)  1Q22 NIM of 1.26%, up 7bps vs. 4Q21, increased asset yields and volumes were partly offset by higher liability costs  1Q22 reported NII was up $0.2bn (3%) vs. 4Q21, more than offsetting a lower day count  Continued improvement in interest rate outlook, leading to higher NII expectations going forward Discrete quarterly reported NIM Average interest earning assets (AIEAs), $bn of which: significant items Reported NII, $m 3Q21 (7) 1Q22 4Q21 18 1Q21 2Q21 (2) 6,584 6,514 6,610 6,781 6,997 Reported NIM progression, bps 12 4Q21 Asset yields (6) Liability costs 1 Funding mix 1Q22 119 126 -- 8 of 32 -- 8 1Q22 results Appendix 0.17 0.10 0.24 (0.17) Credit performance Adjusted ECL release/(charge) trend  1Q22 ECL net charge of $642m included:  Net charges relating to Russian counterparties of c.$250m (Stage 2) and c.$160m relating to China CRE (Stage 2&3)  Low overall Stage 3 charges of c.$400m  Our Stage 1-2 coverage remained stable; a c.$600m release of Covid-19-related allowances was partly offset by:  $275m charge for broader Russia- Ukraine war risks and higher inflation risks  $250m management overlay for economic uncertainty  Stage 3 loans at 1.8% of total loans; stable vs. 4Q21  Continue to expect ECL charge to normalise towards 30bps in FY227 ECL release / (charge) as a % of average gross loans and advances ECL release/(charge) by stage, $bn ECL release/(charge) by geography, $m 420 270 639 (451) (642) 1Q21 1Q22 2Q21 4Q21 3Q21 ECL, $m 1Q22 Stage 1-2 Stage 3 Total Wholesale (0.0) (0.3) (0.3) Personal (0.3) (0.1) (0.3) Total (0.3) (0.4) (0.6) 1Q22 4Q21 Hong Kong* (205) (479) Mainland China (73) (48) Other Asia (33) — UK RFB 84 225 HSBC Bank plc (262) 47 Mexico (101) (145) Other (52) (51) Total (642) (451) * 1Q22 and 4Q21 charge largely relates to offshore China CRE exposures booked on Hong Kong balance sheets (0.25) -- 9 of 32 -- 9 1Q22 results Appendix Adjusted costs 208 422 1Q21 7,998 (580) Cost saves 41 Marketing, T&E 1Q22 (232) PRP Tech spend 9 Other items* 7,857 (2)% PRP 8,180 Cost saves 4Q21 (176) (55) Marketing, T&E 13 128 Tech spend9 (233) Other items* 7,857 1Q22 (4)% Operating expenses trend, $m 1,543 1,438 1,424 1,540 1,649 6,455 8,296 1Q22 7,857 4Q21 1Q21 6,356 2Q21 3Q21 7,445 116 6,640 6,208 7,998 7,794 Other Group costs UK bank levy Technology 8 1Q22 vs. 1Q21, $m 1Q22 vs. 4Q21 (excl. levy), $m  1Q22 costs of $7.9bn, down $0.1bn (2%) vs. 1Q21, as cost saves and lower performance-related pay (PRP) was offset by higher technology spend, investment, volume growth and inflation  1Q22 cost saves of $0.6bn had associated CTA of $0.4bn; programme cost saves to date of $3.9bn and associated CTA spend of $4.1bn  Continue to expect FY22 adjusted costs in line with FY21 * Other items includes: inflation, volume growth and investments 6,021 -- 10 of 32 -- 10 1Q22 results Appendix Capital adequacy 1Q21 4Q21 1Q22 Common equity tier 1 capital, $bn 134.5 132.6 121.4 Reported risk-weighted assets, $bn 846.8 838.3 862.3 CET1 ratio1 , % 15.9 15.8 14.1 Leverage ratio exposure, $bn 2,930.2 2,962.7 2,532.9 Leverage ratio1 , % 5.4 5.2 5.7 Capital progression  CET1 ratio of 14.1%, down 1.7ppts vs. 4Q21. CET1 capital decreased by $11.2bn, mainly due to:  Negative after-tax OCI movements: $3.1bn  Software capitalisation benefit reversal: $2.9bn  Higher threshold deductions: $2.2bn, primarily due to lower absolute levels of CET1 capital and acquisitions  Reported RWAs of $862bn, up $24bn (3%) vs. 4Q21, including a decrease of $9bn from FX moves:  $27bn increase from regulatory changes  RWA increases from loan growth mitigated by improved asset quality and model updates  CET1 ratio for the remainder of FY22 will be impacted by:  France loss on disposal in 3Q22: c.35bps  Acquisitions closing in 2H22: c.7bps  We aim to be within our c.14—14.5% target range at FY22, but CET1 could dip below that in the interim e.g. on the realisation of the French retail loss on sale  $1bn buyback announced in February 2022 expected to start in May; further buybacks unlikely in 2022 due to lower CET1 ratio. Buybacks remain within our capital management toolkit CET1 ratio, % Profits (net of dividend accrual) 10 14.1 Regulatory changes* (0.1) FX translation differences Movements through OCI (0.5) Other movements 1Q22 0.1 (0.4) (0.8) 4Q21 15.0 (0.0) Buyback 15.8 132.6 838.3 121.4 CET1, $bn RWAs, $bn 862.3 27.1 (8.5) (3.1) (3.7) (1.0) 1.1 Net of $1.5bn regulatory dividend deduction (3.2) 5.4 Includes $2.2bn of increased threshold deductions (1.3) * Regulatory changes include impacts from software capitalisation benefit reversal, IRB repair and the UK’s implementation of the CRR II rules; includes $0.2bn of related threshold deductions not included in other movements -- 11 of 32 -- 11 1Q22 results Appendix Conclusion 3 Broader loan growth beginning to come through 2 Costs well under control; firmly on track to meet our FY22 cost target 1 Good set of results, with negative insurance market impacts and weakness in Investment Distribution balanced by strong Personal Banking, CMB and GBM performance 4 More confident of achieving our RoTE ambition of >10% for FY23 11; strategy execution remains on track -- 12 of 32 -- 12 Que everisque iminvendis et accusdam ipsa volesto tatemod ioribus et eum qui resti aute volupta cum apit quatisquunt quate volorepel is incium assi ilibere ssitat. Section title Appendix -- 13 of 32 -- 13 1Q22 results Appendix Russia exposures  Our exposures booked in Russia were $1.3bn at 1Q22, including $0.9bn of local currency deposits with banks  Wholesale exposures booked outside of Russia were $0.4bn, primarily Russian banks and corporates in HSBC Bank (NRFB) Assets $m Third party assets Loans and advances to banks* 898 Loans and advances to customers 72 Reverse repo 135 Cash and balances at central bank 4 Other third party assets 74 Intercompany assets 348 Total assets 1,531 Russian entity balance sheet detail and Russia exposures Liabilities and equity $m Third party liabilities Customer accounts 1,180 Other third party liabilities 59 Intercompany liabilities 141 Total liabilities 1,380 Equity 151 Total liabilities and equity 1,531 * Loans and advances to banks includes $0.8bn of cash balances held at the Central Bank of the Russian Federation Wholesale exposures booked outside of Russia, $bn 0.4 Off-balance sheet unfunded commitments, $bn 0.2 At 31 March 2022 -- 14 of 32 -- 14 1Q22 results Appendix Key financial metrics Reported results, $m 1Q22 4Q21 1Q21 NII 6,997 6,781 6,514 Other Income 5,467 5,208 6,472 Revenue 12,464 11,989 12,986 ECL (642) (450) 435 Costs (8,312) (9,544) (8,527) Associate income 656 669 885 Profit before tax 4,166 2,664 5,779 Tax (723) (635) (1,211) Profit after tax 3,443 2,029 4,568 Profit attributable to ordinary shareholders (‘PAOS’) 2,803 1,788 3,880 Basic earnings per share, $ 0.14 0.09 0.19 Diluted earnings per share, $ 0.14 0.09 0.19 Dividend per share (in respect of the period), $ — 0.18 — Net interest margin (annualised), % 1.26 1.19 1.21 Alternative performance measures, $m 1Q22 4Q21 1Q21 Adjusted NII 6,999 6,745 6,338 Adjusted other income 5,550 5,275 6,624 Adjusted revenue 12,549 12,020 12,962 Adjusted ECL (642) (451) 420 Adjusted costs (7,857) (8,296) (7,998) Adjusted associate income 656 672 896 Adjusted profit before tax 4,706 3,945 6,280 PAOS excl. goodwill and other intangible impairment and PVIF 2,624 2,373 3,940 Return on average tangible equity (annualised), % 6.8 6.0 10.2 Return on average equity (annualised), % 6.5 4.0 9.0 Adjusted net loans and advances to customers 1,055,307 1,033,901 1,016,695 Adjusted customer accounts 1,709,685 1,688,509 1,611,220 Adjusted cost efficiency ratio, % 62.6 69.0 61.7 ECL charge/(release) as a % of average gross loans and advances to customers (annualised) 0.25 0.17 (0.17) Reported balance sheet, $m 1Q22 4Q21 1Q21 Total assets 3,021,512 2,957,939 2,958,629 Net loans and advances to customers 1,055,307 1,045,814 1,040,207 Customer accounts 1,709,685 1,710,574 1,650,019 Quarterly average interest-earning assets 2,259,198 2,251,433 2,178,918 Reported loans and advances to customers as % of customer accounts 61.7 61.1 63.0 Total shareholders’ equity 196,293 198,250 199,210 Tangible ordinary shareholders’ equity 155,833 158,193 157,357 Net asset value per ordinary share at period end, $ 8.71 8.76 8.64 Tangible net asset value per ordinary share at period end, $ 7.80 7.88 7.78 Capital, leverage and liquidity 1Q22 4Q21 1Q21 Reported risk-weighted assets, $bn 862.3 838.3 846.8 CET1 ratio, % 14.1 15.8 15.9 Total capital ratio (transitional), % 19.2 21.2 21.6 Leverage ratio, % 5.7 5.2 5.4 High-quality liquid assets (liquidity value), $bn 695 717 695 Liquidity coverage ratio, % 134 138 143 Share count, m 1Q22 4Q21 1Q21 Basic number of ordinary shares outstanding 19,968 20,073 20,226 Basic number of ordinary shares outstanding and dilutive potential ordinary shares 20,134 20,189 20,335 Quarterly average basic number of ordinary shares outstanding 20,024 20,152 20,191 -- 15 of 32 -- 15 1Q22 results Appendix Reconciliation of reported and adjusted PBT $m 1Q22 4Q21 1Q21 Reported PBT 4,166 2,664 5,779 Revenue Currency translation — (71) (309) Customer redress programmes 2 7 (18) Fair value movements on financial instruments 162 (16) 239 Restructuring and other related costs* (79) 112 66 Currency translation of significant items — (1) (2) 85 31 (24) ECL Currency translation — (1) (15) Operating expenses Currency translation — 47 213 Customer redress programmes 4 25 (10) Impairment of goodwill and other intangibles — 587 — Restructuring and other related costs 451 591 334 o/w: costs to achieve 435 574 319 Currency translation of significant items — (2) (8) 455 1,248 529 Share of profit in associates and joint ventures Currency translation — 3 11 — 3 11 Total currency translation and significant items 540 1,281 501 Adjusted PBT 4,706 3,945 6,280 Memo: tax on significant items (at reported FX rates) (65) (101) (74) * Primarily comprises losses associated with RWA reduction commitments -- 16 of 32 -- 16 1Q22 results Appendix Certain items included in adjusted revenue Certain items included in adjusted revenue highlighted in management commentary, $m 1Q22 4Q21 3Q21 2Q21 1Q21 Insurance manufacturing market impacts in WPB (275) 129 (41) 331 67 of which: Asia WPB insurance manufacturing market impacts (367) 88 (52) 270 (81) Credit and funding valuation adjustments in GBM (32) 43 (48) 3 32 Legacy Credit in Corporate Centre (21) (14) (34) 6 9 Valuation differences on long-term debt and associated swaps in Corporate Centre 5 (10) (35) (27) (28) Total (323) 148 (158) 313 80 -- 17 of 32 -- 17 1Q22 results Appendix (443) 216 (108) 97 61 177 (51) (59) 62 89 (112) (55) (198) (403) (413) 1Q22 adjusted revenue performance 1Q22 revenue 1Q22 vs. 1Q21 Revenue by global business, $bn 12.5 5.6 3.2 5.3 1Q21 4Q21 4.2 3.4 1Q22 0.0 3.5 (0.1) 5.2 3.5 4.0 (0.2) 13.0 12.0 (3)% Corporate Centre WPB CMB GBM o/w XVAs: $(64)m o/w valuation differences: $33m (6)% 9% (4)% of which: GLCM Principal Investments GLCM GTRF Credit and Lending Other Wealth Other $5,231m $3,533m $4,012m $(227)m $12,549m (3)% $1,927m $60m $521m $2,371m $478m $1,020m $1,493m $542m $124m MSS WPB CMB GBM Corp. Centre Group Impact of certain items Banking $1,651m Other $(70)m Personal Banking $3,180m o/w insurance market impacts: $(342)m -- 18 of 32 -- 18 1Q22 results Appendix Net interest margin supporting information 1Q21 2Q21 3Q21 4Q21 1Q22 % of 1Q22 Group NII % of 1Q22 Group AIEA The Hongkong and Shanghai Banking Corporation (HBAP) 1.40% 1.37% 1.35% 1.35% 1.39% 47% 43% HSBC Bank plc (NRFB) 0.51% 0.48% 0.47% 0.52% 0.55% 9% 21% HSBC UK Bank plc (UK RFB) 1.59% 1.56% 1.51% 1.48% 1.63% 25% 19% HSBC North America Holdings, Inc 0.96% 0.97% 0.90% 0.87% 0.90% 6% 8% Quarterly NIM by key legal entity Key rates (quarter averages), bps 14 9 7 11 20 19 8 7 9 8 12 33 10 10 10 13 45 75 2Q21 1Q21 1Q22 3Q21 2Q22 QTD* 4Q21 1M HIBOR Fed effective rate BoE Base Rate Source: Bloomberg * At 22 April 2022 Market-implied path of overnight interest rates12, bps 19 224 279 7 272 334 31/12/2022 31/12/2021 31/12/2023 GBP USD Source: Bloomberg -- 19 of 32 -- 19 1Q22 results Appendix 1Q22 financial highlights Revenue $5.2bn (6)% (1Q21: $5.6bn) ECL $(0.3)bn >(100)% (1Q21: $0.0bn) Costs $(3.8)bn (2)% (1Q21: $(3.7)bn) PBT $1.1bn (40)% (1Q21: $1.9bn) RoTE 13 6.9% (11.9)ppts (1Q21: 18.8%) Wealth and Personal Banking (6)% (1)% (275) 67 129 (41) 331 132 2,110 124 232 2,303 3,180 2,964 1Q21 2,993 2Q21 148 3,012 2,208 3Q21 164 3,084 1,890 1Q22 4Q21 2,202 Revenue performance, $m Wealth excl. market impacts Other Personal banking Balance sheet, $bn Reported Wealth Balances14, $bn 4Q21 1Q21 1Q22 463 824 483 848 488 861 5% 5% Customer lending Customer accounts 1Q22 vs. 1Q21  Revenue down $335m (6%). Personal banking up $216m (7%) from interest rate rises and balance sheet growth. Wealth down $443m, primarily due to adverse insurance market impacts of $342m, lower customer activity in equity markets and the impact of restrictions in Hong Kong, partly offset by higher Insurance (incl. gain on AXA acquisition of $68m)  Customer lending up $25bn (5%), mainly mortgages ($24bn, net of $3bn US balances sold) and unsecured ($1bn)  Customer accounts up $38bn (5%) across most markets, particularly in the UK ($20bn) and HK ($14bn), partly offset by $10bn of reductions related to US sale  Wealth balances stable, wealth deposits up $19bn (5%) and NNIA of $41bn over prior 4 quarters offsetting negative equity market movements on invested assets 1Q22 vs. 4Q21  Revenue down $36m (1%). Personal banking up $96m (3%) from higher global interest rates and balance sheet growth. Wealth down $92m (5%) including adverse insurance market impacts of $404m, partly offset by private banking and seasonality  Customer lending up $5bn (1%), mainly mortgages ($6bn) across most markets, particularly in the UK ($3bn)  Customer accounts up $13bn (2%), driven by growth across most markets, particularly in Hong Kong ($6bn) and the UK ($4bn)  Wealth balances down $31bn (2%) primarily due to lower market levels of ($31bn). NNIA of $9bn, mainly in Asia ($8bn) Insurance manufacturing market impacts 5,566 5,566 5,327 5,267 5,231 0% 1Q21 557 538 1,096 1,082 551 1,119 4Q21 1Q22 1,633 1,670 1,639 (2)% Invested assets Wealth deposits -- 20 of 32 -- 20 1Q22 results Appendix 1Q22 financial highlights Revenue $3.5bn 9% (1Q21: $3.2bn) ECL $0.0bn (95)% (1Q21: $0.2bn) Costs $(1.7)bn (1)% (1Q21: $(1.7)bn) PBT $1.8bn 3% (1Q21: $1.8bn) RoTE 13 12.1% 0.6ppts (1Q21: 11.5%) 9% 6% Commercial Banking Balance sheet, $bn 4Q21 1Q21 1Q22 345 336 355 3% 1Q22 4Q21 1Q21 460 500 499 (0)% Customer lending Customer accounts Revenue performance, $m 1Q22 vs. 1Q21  Revenue up $284m (9%) across all regions and core CMB products, notably in GLCM and GTRF (up over 20% each) reflecting higher volumes at improved margins with double digit growth in fees and GBM collaboration income  Customer lending up $19bn (6%), balances above pre- pandemic levels with growth notably in Asia, across Trade (up $12bn, 25%) and C&L (up $5bn)  Customer accounts up $40bn (9%) with balance growth across all regions, notably in Asia and the UK 1Q22 vs. 4Q21  Revenue up $168m (5%) reflecting higher GLCM margins in part from interest rate rises, continued fee growth notably in Trade and higher Insurance in Asia reflecting seasonality, GBM collaboration income (up 16%), partially offset by 4Q C&L one-off gains  Customer lending up $9bn (3%) with growth across all regions, notably C&L (up $6bn) in Asia and North America with continued momentum in Trade (up $3bn)  Customer accounts remain stable despite 1Q seasonal outflows 9% GLCM Credit and Lending GTRF Markets products, Insurance and Investments and Other 466 445 3,220 542 3Q21 843 449 1Q21 854 2Q21 447 492 1,492 1,432 3,249 879 369 3,310 509 1,556 931 4Q21 478 529 1,493 1,020 1Q22 1,451 3,365 3,533 5% -- 21 of 32 -- 21 1Q22 results Appendix 1Q22 financial highlights Revenue $4.0bn (4)% (1Q21: $4.2bn) ECL $(0.3)bn >(100)% (1Q21: $0.2bn) Costs $(2.5)bn (0)% (1Q21: $(2.5)bn) PBT $1.2bn (35)% (1Q21: $1.9bn) RoTE 13 8.2% (3.9)ppts (1Q21: 12.1%) Global Banking and Markets View of adjusted revenue Adjusted RWAs15, $bn 2,430 1,888 1,951 1,857 2,371 1,589 1,618 1,631 1,648 1,651 (52) (10) 2Q21 157 1Q21 (34) 3Q21 (13) 4Q21 1Q22 4,176 3,472 3,492 3,530 4,012 (4)% 15% Banking MSS Other Revenue performance, $m $m 1Q22 ∆1Q21 MSS 2,371 (2)% Securities Services 489 11 % Global Debt Markets 208 (46)% Global FX 1,070 15 % Equities 417 2 % Securities Financing 219 (6)% XVAs (32) >(100)% Banking 1,651 4 % GTRF 185 6 % GLCM 521 21 % Credit & Lending 607 (5)% Capital Markets & Advisory 290 2 % Other 48 (23)% GBM Other (10) >(100)% Principal Investments 60 (65)% Other (70) >(100)% Net operating income 4,012 (4)% 1Q22 vs. 1Q21  Revenue down 4% vs. 1Q21: • Global FX and Equities benefitted from strong trading performance driven by market volatility • Securities Services growth driven by global rate increases, supported by resilient fee generation • Global Debt Markets adversely impacted by market conditions, lack of primary activity and subdued client activity • GLCM up reflecting higher global interest rates coupled with increase in average deposits and fee growth across all regions • Capital Markets and Advisory revenue stable year on year with the slowdown in Equity Capital Markets and Debt Capital Markets, offset by continued growth in US Leveraged and Acquisition Finance • Credit & Lending impacted by strategic actions taken to reduce RWAs • Principal Investments impacted by lower revaluation gains  Cumulative RWA savings16 of $83bn achieved since the start of our transformation programme 1Q22 vs. 4Q21  Revenue up $520m (15%): • MSS up $514m (28%), reflecting increased activity vs. 4Q21 • Banking revenue stable, increases in GLCM were offset by lower Credit & Lending 1Q22 1Q21 4Q21 243 250 234 (3)% 4% -- 22 of 32 -- 22 1Q22 results Appendix 1Q22 financial highlights Revenue $(227)m >(100)% (1Q21: $(29)m) ECL $(2)m —% (1Q21: $(2)m) Costs $110m >100% (1Q21: $(114)m) Associates $648m (27)% (1Q21: $887m) PBT $529m (29)% (1Q21: $742m) RoTE 13 6.2% (1.2)ppts (1Q21: 7.4%) Corporate Centre Revenue performance, $m 716 658 549 578 672 102 14 133 38 1Q21 100 19 2Q21 887 66 3Q21 70 4Q21 (2) (22) 1Q22 779 715 662 648 (2)% Associate income detail, $m 1Q21 2Q21 3Q21 4Q21 1Q22 Central Treasury (28) (27) (35) (10) 5 Legacy Credit 9 6 (34) (14) (21) Other (10) (57) (115) (80) (211) Total (29) (78) (184) (104) (227) Not included in Corporate Centre revenue: Markets Treasury revenue allocated to global businesses 783 500 514 490 503 SABB BoComm Others 1Q22 vs. 4Q21  Revenue down $123m due to FX losses on hedges  Associates down $14m (2%), primarily due to a lower share of profit from associates in the MENA and the UK, partly offset by Asia 1Q22 vs. 1Q21  Revenue down $198m, largely due to intersegment eliminations with GBM and FX losses on hedges  Associates down $239m (27%), primarily due to the non- recurrence of 1Q21 revaluation gains in BGF Adjusted RWAs15, $bn 51 52 40 90 53 4Q21 1Q21 39 37 1Q22 93 90 (2)% (0)% Associates Other -- 23 of 32 -- 23 1Q22 results Appendix 1Q22 vs. 4Q21 equity drivers Shareholders’ Equity, $bn Tangible Equity, $bn TNAV per share, $ Basic number of ordinary shares, million As at 31 December 2021 198.3 158.2 7.88 20,073 Profit attributable to: 3.3 2.9 0.15 — Ordinary shareholders 17 2.8 2.9 0.15 — Other equity holders 0.5 — — — Dividends (0.5) — — — On ordinary shares — — — — On other equity instruments (0.5) — — — Cancellation of shares — — — (117) FX 17 (1.8) (1.6) (0.08) — Actuarial gains/(losses) on defined benefit plans 0.7 0.7 0.03 — Fair value movements through ‘Other Comprehensive Income’ (2.2) (2.2) (0.11) — Of which: changes in fair value arising from changes in own credit risk 0.9 0.9 0.04 — Of which: Debt and Equity instruments at fair value through OCI (3.0) (3.0) (0.15) — Other 17 (1.5) (2.2) (0.07) 12 As at 31 March 2022 196.3 155.8 7.80 19,968  Average basic number of shares outstanding during 1Q22: 20,024m  1Q22 TNAV per share decreased by $0.08 to $7.80 per share mainly due to FX and fair value movements through OCI, partly offset by profits  1Q22 TNAV excludes the impact of the 2nd interim dividend in respect of FY21 of $0.18 per share, to be paid at the end of April $7.74 on a fully diluted basis 20,134 million on a fully diluted basis -- 24 of 32 -- 24 1Q22 results Appendix Total shareholders’ equity to CET1 capital 1Q22 4Q21 Total equity (per balance sheet) 204,658 206,777 Non-controlling interests (8,365) (8,527) Total shareholders’ equity 196,293 198,250 Additional Tier 1 (22,414) (22,414) Total ordinary shareholders' equity 173,879 175,836 Foreseeable dividend (5,197) (3,655) Share buyback (1,000) — Deconsolidation of insurance/SPE's (13,479) (13,449) Allowable NCI in CET1 4,297 4,186 CET1 before regulatory adjustments 158,500 162,918 Prudential valuation adjustment (1,419) (1,217) Intangible assets (11,899) (9,123) Deferred tax asset deduction (1,579) (1,520) Cash flow hedge adjustment 1,297 170 Excess of expected loss (2,304) (2,020) Own credit spread and debit valuation adjustment 671 1,571 Defined benefit pension fund assets (7,797) (7,146) Direct and indirect holdings of CET1 instruments (40) (40) Other regulatory adjustments to CET1 capital (including IFRS 9 transitional adjustments when relevant) 223 766 Threshold deductions (14,206) (11,794) Regulatory adjustments (37,053) (30,353) CET1 capital 121,447 132,565 CET1 capital Foreseeable dividend (1,000) Total equity Other equity instruments (22,414) (13,479) Total shareholder’s equity (5,197) Non-controlling interests CET1 before regulatory adjustments Regulatory adjustments 173,879 121,447 158,500 Share buyback 196,293 Allowable NCI in CET1 (8,365) Deconsolidation of insurance / SPEs 4,297 Total ordinary shareholder’s equity (37,053) 204,658 Total equity to CET1 capital, at 31 March 2022, $m Total equity to CET1 capital walk, $m -- 25 of 32 -- 25 1Q22 results Appendix Impacts of financial investments  As part of our interest rate hedging strategy, we hold a portfolio of financial investments measured at fair value through other comprehensive income (‘FVOCI’), which are classified as hold-to-collect-and-sell (‘HTC&S’) 18; the change in value of these instruments is recognised in equity  These instruments are a component of a partial economic hedge of our interest rate risk position and included in the Group’s disclosed interest rate sensitivity table calculations; the disclosed interest rate sensitivity shown in the tables is net of these hedging positions  The Group remains positively exposed to global interest rate movements (incremental NII of $5.4bn over 12 months for a parallel shift of +100bps 20)  At FY21 we held $349bn of financial investments FVOCI, of which: $247bn debt securities; $97bn US Treasury bills and similar securities  The increase in term market yield curves in 1Q22 drove a pre-tax FVOCI loss of $3.9bn on HTC&S positions, with a post-tax FVOCI loss of $3.1bn  Between 31 March 2022 and 19 April 2022, there has been an additional pre-tax FVOCI loss of c.$1bn due to the continued steepening of yield curves  The increases in yield curves and short rates will benefit Group NII. If policy rates were to follow market expectations, higher NII is expected to offset FVOCI losses through increased profitability in 4-6 quarters* (from 31 March 2022) Debt instruments at FVOCI by product19 Financial investments measured at fair value through OCI  Portfolio durations of debt securities measured at FVOCI typically between 6 months to 10 years; average duration of 4 years  USD securities (incl. US Government agencies and sponsored entities) are longer duration, and HKD securities are shorter duration 22% 4% 44% 14% 16% US sovereign debt UK sovereign debt Corporate debt and other securities Hong Kong sovereign debt Other government debt At 31 December 2021 * Based on a static portfolio composition -- 26 of 32 -- 26 1Q22 results Appendix 1Q21 4Q21 1Q22 4% Balance sheet – customer lending 217 463 1 336 483 1,034 205 345 1 488 355 213 0 1,017 1,055 2% Balances by global business, $bn Corporate Centre GBM CMB WPB Adjusted customer lending of $1,055bn, up $21bn (2%) vs. 4Q21  WPB lending increased by $5bn (1%), mainly mortgages (up $6bn), particularly in the UK  CMB lending increased by $9bn (3%), mainly C&L across all regions and continued growth in trade  GBM lending up $7bn (4%), primarily seasonality in GLCM Balances by region, $bn Europe Asia MENA North America o/w: US Total o/w: Hong Kong o/w: UK Latin America 3 $3bn 3% 1 $7bn 1% $10bn 3% $11bn 4% $1bn 3% $1bn 3% $(0)bn (0)% $1bn 2% $21bn 2% Growth since 4Q21 o/w: mortgages o/w: mortgages $396bn $498bn $27bn $113bn $22bn $1,055bn $308bn $310bn $54bn -- 27 of 32 -- 27 1Q22 results Appendix 6% 460 824 1 327 848 1Q21 861 500 339 1 1 4Q21 499 1Q22 348 1,611 1,689 1,710 1% Balance sheet – customer accounts Balances by global business, $bn Adjusted customer accounts of $1,710bn, up $21bn (1%) vs. 4Q21  WPB customer accounts up $13bn (2%), driven by growth across most markets, particularly in Hong Kong ($6bn) and the UK ($4bn)  CMB customer accounts stable despite seasonal outflows  GBM customer accounts up $9bn (3%), due to GLCM seasonality CMB WPB GBM Corporate Centre Balances by region, $bn Europe Asia MENA North America o/w: US Total o/w: Hong Kong o/w: UK Latin America $6bn 1% $1bn 4% $16bn 3% $21bn 1% $15bn 3% $9bn 2% $3bn 6% $(5)bn (3)% $(4)bn (4)% Growth since 4Q21 $666bn $795bn $44bn $174bn $31bn $1,710bn $535bn $556bn $108bn -- 28 of 32 -- 28 1Q22 results Appendix Glossary AIEA Average interest earning assets AT1 Additional Tier 1 BGF Business Growth Fund, an associate of HSBC BoCom Bank of Communications Co. Limited, an associate of HSBC Bps Basis points. One basis point is equal to one-hundredth of a percentage point CET1 Common Equity Tier 1 Corporate Centre Corporate Centre comprises Central Treasury, our legacy businesses, interests in our associates and joint ventures and central stewardship costs CMB Commercial Banking, a global business CRE Commercial Real Estate CTA Costs to achieve C&L Credit and Lending ECL Expected credit losses. In the income statement, ECL is recorded as a change in expected credit losses and other credit impairment charges. In the balance sheet, ECL is recorded as an allowance for financial instruments to which only the impairment requirements in IFRS 9 are applied GBM Global Banking and Markets, a global business GLCM Global Liquidity and Cash Management GPB Global Private Banking Group HSBC Holdings plc and its subsidiary undertakings GSS Green, Social and Sustainability GTRF Global Trade and Receivables Finance HIBOR Hong Kong Interbank Offered Rate IFRS International Financial Reporting Standard IPO Initial Public Offering LCR Liquidity coverage ratio Legacy credit A portfolio of assets including securities investment conduits, asset-backed securities, trading portfolios, credit correlation portfolios and derivative transactions entered into directly with monoline insurers MENA Middle East and North Africa MSS Markets and Securities Services NCI Non-controlling interests NII Net interest income NIM Net interest margin NNIA Net new invested assets NRFB Non ring-fenced bank in Europe and the UK OCI Other Comprehensive Income PBT Profit before tax Ppt Percentage points PVIF Present value of in-force insurance contracts SABB The Saudi British Bank, an associate of HSBC UK RFB HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank legislation RoTE Return on average tangible equity RWA Risk-weighted asset TNAV Tangible net asset value T&E Travel and entertainment VNB Value of new business written WPB Wealth and Personal Banking, a global business XVAs Credit and Funding Valuation Adjustments -- 29 of 32 -- 29 1Q22 results Appendix Footnotes 1. Unless otherwise stated, regulatory capital ratios and requirements are based on the transitional arrangements of the Capital Requirements Regulation in force at the time. These include the regulatory transitional arrangements for IFRS 9 ‘Financial Instruments’. The leverage ratio is calculated using the end point definition of capital and the IFRS 9 regulatory transitional arrangements, in line with the UK leverage rules that were implemented on 1 January 2022, and excludes central bank claims. Comparatives for 2021 are reported based on the disclosure rules in force at that time, and include claims on central banks. References to EU regulations and directives (including technical standards) should, as applicable, be read as references to the UK’s version of such regulation and/or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018, and subsequently amended under UK law 2. Source: Dealogic from 1 January 2022 - 21 April 2022. Ranking based on apportioned deal amount by bookrunner 3. For further information please see our press release titled: “HSBC announces net zero steps” on hsbc.com 4. Source: Dealogic at 31 March 2022, data as at 22 April 2022. Global GSS bonds 5. Percentage is calculated excluding self-service machine transactions (excludes HASE and GPB) 6. Reported RoTE is computed by adjusting annualised reported results for PVIF and for impairment of goodwill and other intangible assets (net of tax), divided by average reported equity adjusted for goodwill, intangibles and PVIF for the period 7. Based on current consensus economic forecasts and default experience 8. Technology costs in operating expenses trends include transformation saves and are presented on a net basis 9. Technology cost increases in quarterly walks are presented on a gross basis (excl. saves) 10. Regulatory dividend accrual for the purposes of capital calculations. Over 1Q22 we accrued 7.6¢, equal to 55% of reported EPS of 14¢. In line with our dividend policy, we will retain the flexibility to adjust EPS for non-cash significant items. Additionally, in 2022, we expect to exclude from EPS the forecast loss on the sale of our retail banking operations in France 11. If policy rates were to follow the current implied market consensus 12. Source: Bloomberg. GBP: Sterling Overnight Index Average (SONIA); USD: Fed funds. Implied rates for 31 December 2022 and 2023 based on the following as of 22 April 2022: 30 day Fed Funds futures and one month SONIA index future 13. YTD, annualised. RoTE by Global Business excludes significant items. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric. RoTE by Global Business considers AT1 Coupons on an accruals basis, vs. Reported RoTE where it is treated on a cash basis 14. Wealth deposits include Premier, Jade and Global Private Banking deposits, which include Prestige deposits in Hang Seng Bank, and form part of the total WPB customer accounts balance 15. Data to reconcile components of reported RWAs to adjusted RWAs can be found in the ‘HSBC Holdings plc 1Q 2022 Datapack’ 16. Cumulative RWA saves under our transformation programs as measured from 1 January 2020, including $9.6bn of accelerated saves made over 4Q19 17. Differences between shareholders’ equity and tangible equity drivers primarily reflect AT1 capital, goodwill and other intangibles and PVIF. ‘Profit Attributable to Ordinary shareholders’ differences primarily include goodwill and other intangibles impairment, PVIF movements and amortisation expense. ‘FX’ differences primarily include FX on goodwill and intangibles. ‘Other’ differences primarily include intangible additions and redemption of securities 18. HTC&S portfolio stressed value at risk (VaR) of $3.6bn at FY21. HTC&S portfolio stressed VaR assumes a holding period of 60 days; details on sensitivity of capital and reserves can be found on p.201 of the 2021 HSBC Holdings plc Annual Report and Accounts; additional quantitative information on interest rate risk in the banking book, including changes in the economic value of equity in relation to changes in yield curves can be found on p.75 of the HSBC Holdings plc Pillar 3 Disclosures at 31 December 2021 19. Product allocations are made on an amortised cost basis 20. Interest rate sensitivity disclosures can be found on p.200 of the HSBC Holdings plc Annual report and Accounts 2021 -- 30 of 32 -- 30 1Q22 results Appendix Disclaimer Important notice The information, statements and opinions set out in this presentation and accompanying discussion (“this Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any applicable law or an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments. This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries, the “Group”) and has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No responsibility, liability or obligation (whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified Person”) as to or in relation to this Presentation (including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such liability is expressly disclaimed. No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or oral information provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update, revise or supplement this Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past performance and actual results may be material and adverse. Forward-looking statements This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and business of the Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and "reasonably possible" or the negatives thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and any ESG related targets, commitments and ambitions described herein. Any such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective judgements which may or may not prove to be correct. There can be no assurance that any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The assumptions and judgments may prove to be incorrect and involve known and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements, results, performance or other future events or conditions may differ materially from those stated, implied and/or reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without limitation those which are referable to general market conditions, regulatory changes, geopolitical tensions such as the Russia-Ukraine war, the impact of the Covid-19 pandemic or as a result of data limitations and changes in applicable methodologies in relation to ESG related matters). Any such forward-looking statements are based on the beliefs, expectations and opinions of the Group at the date the statements are made, and the Group does not assume, and hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions should change. For these reasons, recipients should not place reliance on, and are cautioned about relying on, any forward-looking statements. No representations or warranties, expressed or implied, are given by or on behalf of the Group as to the achievement or reasonableness of any projections, estimates, forecasts, targets, commitments, prospects or returns contained herein. Additional detailed information concerning important factors that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for the fiscal year ended 31 December 2021 filed with the Securities and Exchange Commission (the “SEC”) on Form 20-F on 23 February 2022 (the “2021 Form 20-F”) and our 1Q 2022 Earning Release which we expect to furnish with the SEC on Form 6-K on 26 April 2022 (the “Q1 2022 Earnings Release”). Alternative Performance Measures This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in and presented in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on an “adjusted performance” basis which is computed by adjusting reported results for the period-on-period effects of foreign currency translation differences and significant items which distort period-on-period comparisons. Significant items are those items which management and investors would ordinarily identify and consider separately when assessing performance in order to better understand the underlying trends in the business. Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 2021 Form 20-F and our Q1 2022 Earnings Release, when filed, each of which are available at www.hsbc.com. Information in this Presentation was prepared as at 26 April 2022. -- 31 of 32 -- -- 32 of 32 --